Zobrazeno 1 - 10
of 14
pro vyhledávání: '"José M. Tabernero"'
Autor:
José M. Tabernero, Ulrich Kunzendorf, Ferdinand Mühlbacher, Raimund Margreiter, Bernd Krüger, Hans-Krister Stummvoll, Manuel Rivero, Heide Sperschneider, Joaquín Ortuño, Bernhard K. Krämer, Domingo Del Castillo, H. Köhler, Giuseppe Montagnino, Christoph J. Olbricht, Manuel Arias
Publikováno v:
Nephrology Dialysis Transplantation. 20:968-973
BACKGROUND: Comparison studies of calcineurin inhibitors as cornerstone immunosuppressants in renal transplantation have demonstrated that tacrolimus consistently reduces acute rejection rates and, in some studies, also improves long-term renal outco
Autor:
Manuel Heras, jose luis lerma, Corbacho L, Pedro L. García, Antonio Bondía, Jesús Garrido, Pedro J. Labrador, José M. Tabernero
Publikováno v:
American Journal of Kidney Diseases. 41:488-492
The authors report 2 cases of patients who underwent cadaveric renal transplantation from the same donor in a multiorgan extraction procedure. Both cases showed, during the first 6 months posttransplantation, a worsening in renal graft function and s
Autor:
Gerard Murphy, Azemi A. Barama, Sophie Fornairon, P. Vialtel, Marco Castagneto, D. Del Castillo, Paul Keown, Franco Citterio, T. Romanet, Greg Knoll, G. Boschiero, D. Uehlinger, N. Muirhead, Ferenc Perner, Tufveson, P. Szenohradszky, Robert Balshaw, David Ludwin, E. Ancona, J. P. Wauters, Paolo Rigotti, Lyse Beauregard-Zollinger, F. Ortega, Hans Prestele, G. Ancona, D. Casadei, Edward H. Cole, Lars Bäckman, José M. Tabernero, Horvath, C. Pouteil-Noble
Publikováno v:
American Journal of Transplantation. 2:157-166
Increasing information suggests that absorption profiling may be superior to trough level monitoring for optimal concentration control of cyclosporine microemulsion (Neoral) therapy, and that CsA exposure early post-transplant may correlate significa
Autor:
Pilar Fraile, Luis Maria Cacharro, Consolacion Rosado, José M. Tabernero, Pedro Garcia-Cosmes
Publikováno v:
NDT Plus
Lanthanum carbonate is a nonaluminum, noncalcium phosphate-binding agent, which is widely used in patients with end-stage chronic kidney disease. Until now, no significant side-effects have been described for the clinical use of lanthanum carbonate,
Autor:
José M. Tabernero Romo, Javier Deira Lorenzo, Serafina Sanchez Martin, Mariano Martin Rodriguez
Publikováno v:
American Journal of Kidney Diseases. 37:550-556
The Erythropoietic Activity (EA) and degree of erythropoiesis attained by patients undergoing hemodialysis (HD) administered recombinant human erythropoietin (rHuEPO) were studied using ferrokinetic measurements and tests of soluble transferrin recep
Publikováno v:
American Journal of Kidney Diseases. 32:575-581
Different immunosuppressive agents, in particular OKT3, have been implicated as causative factors in the risk for renal thrombosis in the period immediately after kidney transplantation. Also, in different types of vascular surgery, a state similar t
Autor:
Pilar Fraile, Marcos Alvarez, Tamara Garcia, José M. Tabernero, Pedro Garcia-Cosmes, Corbacho L
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 24(6)
The prevalence of psychiatric disorders in dialyzed patients is estimated around 5-20% of the cases. This explains the high use of antidepressant drugs in these patients. We present the case of a 68-year-old woman with a history of renal failure, wit
Autor:
Pilar Fraile, Cristina Lucas Álvarez, Pedro Garcia-Cosmes, Sofía del Carmen Martínez, José M. Tabernero
Publikováno v:
Clinical Kidney Journal
The most frequent complications that occur after the completion of an internal arteriovenous fistula are thrombotic. Other complications, such as infection, cardiac decompensation, aneurysm/pseudoaneurysm or median nerve injury, are less common. None
Publikováno v:
Cancer. 97
Pemetrexed disodium (ALIMTa, [pemetrexed], LY231514; Eli Lilly and Company; Indianapolis, IN), a novel antifolate antimetabolite with multiple enzyme targets involved in both pyrimidine and purine synthesis, has entered clinical trials due to its fav
Autor:
Javier Deira, Mariano Martín, José M. Tabernero, Jesús Núñez, Serafina Sánchez, Jesús Garrido
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 39(3)
Intestinal iron absorption was evaluated in 40 patients on hemodialysis therapy treated over 4 months with 105 mg/d of oral iron and recombinant human erythropoietin (rHuEPO). The effect of iron stores, erythropoietic activity (EA), and route of rHuE